TEM · Tempus AI, Inc. · Earnings Call Transcripts & Audio
$81.62
-0.96 (-1.16%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$15.34B
Shares
180.43M
Volume · Sep 30
4.57M
Avg daily vol (3M)
6.5M
Tempus AI, Inc. Earnings Call Transcripts
Quarterly earnings calls for Tempus AI, Inc. (TEM), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲25.3%
$165.97M
−$552.21M
'24 Q2
24-08-06
▲33%
$180.93M
−$75.84M
'24 Q3
24-11-04
·
$200.68M
−$13.01M
'24 Q4
25-02-24
▲75.4%
$255.74M
−$68.04M
'25 Q1
25-05-06
▲89.6%
$314.63M
−$42.84M
'25 Q2
25-08-08
▲84.7%
$334.21M
−$79.98M
'25 Q3
25-11-04
▲83%
$367.21M
−$54.17M
'25 Q4
26-02-24
▲36.1%
$348.12M
−$125.92M
'26 Q1
26-05-05
LATEST
▲21.6%
$382.49M
$5.64M
'26 Q2
26-07-30
Earnings call
FY26 · Q2
2026-07-30
Tempus AI, Inc. (TEM) Q2 2026 Earnings Call Transcript
Confident tone
Personalis acquisition (MRD)
Data and Apps / pharma deals
FDA approvals and ASP uplift
Revenue
$382.49M
▲ 21.6% YoY Diluted EPS
$0.03
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-08
Tempus AI, Inc. (TEM) June 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Capital Markets Day
Investor event
2026-05-29
Tempus AI, Inc. (TEM) May 2026 Capital Markets Day Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-05
Tempus AI, Inc. (TEM) Q1 2026 Earnings Call Transcript
Confident tone
MRD / Reimbursement Constraints
Diagnostics / Oncology Growth
Data & Apps / Insights Business
Revenue
$348.12M
▲ 36.1% YoY Diluted EPS
$-0.71
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-03-03
Tempus AI, Inc. (TEM) March 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-02-24
Tempus AI, Inc. (TEM) Q4 2025 Earnings Call Transcript
Confident tone
Data / Insights Business
Diagnostics Growth
MRD / Tumor-Naive Assay
Revenue
$367.21M*
▲ 83% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-04
Tempus AI, Inc. (TEM) Q3 2025 Earnings Call Transcript
Confident tone
Genomics volume growth
Data licensing / Insights business
Reimbursement for data and algorithms
Revenue
$334.21M
▲ 84.7% YoY Diluted EPS
$-0.46
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-08
Tempus AI, Inc. (TEM) Q2 2025 Earnings Call Transcript
Confident tone
Genomics/Oncology volume growth
AI algorithms and reimbursement
ASP and reimbursement dynamics
Revenue
$314.63M
▲ 89.6% YoY Diluted EPS
$-0.25
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-06
Tempus AI, Inc. (TEM) Q1 2025 Earnings Call Transcript
Confident tone
AZ-Pathos Foundation Model Deal
Data and Services / Insights Business
MRD / Minimal Residual Disease
Revenue
$255.74M
▲ 75.4% YoY Diluted EPS
$-0.40
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-24
Tempus AI, Inc. (TEM) Q4 2024 Earnings Call Transcript
Confident tone
Data and Services Business
Ambry Genetics Acquisition and Integration
Patient-Facing App and Multimodal Data
Revenue
$200.68M*
Rev · 5q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-04
Tempus AI, Inc. (TEM) Q3 2024 Earnings Call Transcript
Confident tone
Ambry Genetics acquisition
MRD and reimbursement
Data and licensing business
Revenue
$180.93M
▲ 33% YoY Diluted EPS
$-0.46
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Tempus AI, Inc. (TEM) Q2 2024 Earnings Call
Revenue
$165.97M
▲ 25.3% YoY Diluted EPS
$-6.86
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Showing 1–12 of 12 earnings calls